- Home
- Publications
- Publication Search
- Publication Details
Title
The use of urine in the follow-up of HPV vaccine trials
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 11, Issue 2, Pages 350-352
Publisher
Informa UK Limited
Online
2015-02-10
DOI
10.4161/21645515.2014.995058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimization of HPV DNA detection in urine by improving collection, storage, and extraction
- (2014) A. Vorsters et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon
- (2014) Archana Chatterjee Expert Review of Vaccines
- Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
- (2014) Marc Arbyn et al. LANCET ONCOLOGY
- Urine testing for HPV: rationale for using first void
- (2014) A. Vorsters et al. BMJ-British Medical Journal
- Monitoring human papillomavirus prevalence in urine samples: a review
- (2013) Espen Enerly et al. Clinical Epidemiology
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Human Papillomavirus Vaccines – Immune Responses
- (2012) Margaret Stanley et al. VACCINE
- Detection of human papillomavirus DNA in urine. A review of the literature
- (2011) A. Vorsters et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Urine testing as a surveillance tool to monitor the impact of HPV immunization programs
- (2011) Kate Cuschieri et al. JOURNAL OF MEDICAL VIROLOGY
- Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
- (2011) R. Herrero et al. Cancer Discovery
- Incidence, Duration, and Reappearance of Type-Specific Cervical Human Papillomavirus Infections in Young Women
- (2010) R. P. Insinga et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
- (2010) N. De Carvalho et al. VACCINE
- A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- (2009) S. K. Kjaer et al. Cancer Prevention Research
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial
- (2009) Nubia Muñoz et al. LANCET
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia
- (2008) Massimiliano Fambrini et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now